Zobrazeno 1 - 10
of 654
pro vyhledávání: '"Demarteau, N."'
Autor:
Peter Hillemanns
Publikováno v:
Journal of Medical Economics. 14:262-266
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5243492badaac1ed6d5538257ee1f1a5
https://doi.org/10.3111/13696998.2011.562580
https://doi.org/10.3111/13696998.2011.562580
Autor:
Hillemanns P
Publikováno v:
Journal of medical economics [J Med Econ] 2011; Vol. 14 (2), pp. 262-6. Date of Electronic Publication: 2011 Mar 09.
Publikováno v:
In Gynecologic Oncology 2011 121(3):514-521
Autor:
Kapoor R; Evidera, PPD Singapore, 08-11, 1 Fusionopolis Walk, Singapore 138628, Singapore., Standaert B; Faculty of Medicine and Life Sciences, University of Hasselt, Agoralaan, 3590 Diepenbeek, Belgium., Pezalla EJ; Enlightenment Bioconsult, LLC, 140 S Beach Street, Suite 310, Daytona Beach, FL 32114, USA., Demarteau N; Evidera, 1932 Brussels, Belgium., Sutton K; Evidera, Melbourne, VIC 3004, Australia., Tichy E; Evidera, H-1113 Budapest, Hungary., Bungey G; Evidera, PPD the Ark, 2nd Floor, 201 Talgarth Road, London W6 8BJ, UK., Arnetorp S; Health Economics & Payer Evidence, BioPharmaceuticals R&D, AstraZeneca, 431 83 Gothenberg, Sweden., Bergenheim K; Health Economics & Payer Evidence, BioPharmaceuticals R&D, AstraZeneca, 431 83 Gothenberg, Sweden., Darroch-Thompson D; International Market Access, Vaccines and Immune Therapies, AstraZeneca, Singapore 339510, Singapore., Meeraus W; Medical Evidence, Vaccines and Immune Therapies, AstraZeneca, Cambridge CB2 8PA, UK., Okumura LM; Health Economics & Payer Evidence, BioPharmaceuticals R&D, AstraZeneca, São Paulo 06709-000, Brazil., Tiene de Carvalho Yokota R; Medical Evidence, Vaccines and Immune Therapies, AstraZeneca, Cambridge CB2 8PA, UK.; P95 Epidemiology & Pharmacovigilance, 3001 Leuven, Belgium., Gani R; Evidera, PPD the Ark, 2nd Floor, 201 Talgarth Road, London W6 8BJ, UK., Nolan T; The Peter Doherty Institute for Infection and Immunity, University of Melbourne, Parkville, VIC 3010, Australia.; Murdoch Children's Research Institute, Parkville, VIC 3052, Australia.
Publikováno v:
Vaccines [Vaccines (Basel)] 2023 Feb 07; Vol. 11 (2). Date of Electronic Publication: 2023 Feb 07.
Autor:
Kapoor, R, Standaert, B, Nolan, T, Pezalla, EJ, Arnetorp, S, Bergenheim, K, Bungey, G, Darroch-Thompson, D, Gani, R, Meeraus, W, Okumura, L, Sutton, K, Tichy, E, Yokota, R, Demarteau, N
Publikováno v:
In Value in Health December 2022 25(12) Supplement:S278-S278
Autor:
Tung-Lin Tsui1,2, Yung-Chuan Ho3, Kwo-Chang Ueng4,5, Pei-Lun Liao6, Jing-Yang Huang1,6, Chia-Yi Lee1,7, Shih-Chi Su8,9 ssu1@cgmh.org.tw, Shun-Fa Yang1,6 ysf@csmu.edu.tw
Publikováno v:
Journal of Cancer. 2024, Vol. 15 Issue 19, p6196-6203. 8p.
Autor:
Lapi, Francesco1 (AUTHOR) lapi.francesco@simg.it, Marconi, Ettore1 (AUTHOR), Cricelli, Iacopo2 (AUTHOR) iacopo.cricelli@genomedics.it, Rossi, Alessandro3 (AUTHOR) rossi.alessandro@simg.it, Mastronuzzi, Tecla3 (AUTHOR) mastronuzzi.tecla@simg.it, Gabutti, Giovanni4 (AUTHOR) gbtgnn@unife.it, Cricelli, Claudio3 (AUTHOR) cricelli@gmail.com
Publikováno v:
Infectious Disease Reports. Oct2024, Vol. 16 Issue 5, p870-879. 10p.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Quiambao B; Research Institute for Tropical Medicine, Filinvest Corporate City, 9002 Research Dr, Alabang, Muntinlupa, 1781 Metro Manila, Philippines. Electronic address: ado.ritmdoh@gmail.com., Varghese L; GSK, 23 Rochester Park, 139234 Singapore, Singapore. Electronic address: lijoy.varghese@outlook.com., Demarteau N; GSK, 20 Fleming Avenue, 1300 Wavre, Belgium. Electronic address: nadiademarteau@gmail.com., Sengson RF; GSK, 23 Rochester Park, 139234 Singapore, Singapore. Electronic address: ruth.r.sengson@gsk.com., Javier J; Research Institute for Tropical Medicine, Filinvest Corporate City, 9002 Research Dr, Alabang, Muntinlupa, 1781 Metro Manila, Philippines. Electronic address: jenaline.javier@gmail.com., Mukherjee P; GSK, 20 Fleming Avenue, 1300 Wavre, Belgium. Electronic address: piyali.x.mukherjee@gsk.com., Manio LC; GSK, 2266 Chino Roces Ave, Makati, 1231 Metro Manila, Philippines. Electronic address: leahmanio@gmail.com., Preiss S; GSK, 20 Fleming Avenue, 1300 Wavre, Belgium. Electronic address: scott.s.preiss@gsk.com.
Publikováno v:
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases [Int J Infect Dis] 2020 Aug; Vol. 97, pp. 38-46. Date of Electronic Publication: 2020 May 22.
Autor:
Aballéa S; Creativ-Ceutical, Paris, France.; Public Health Department-Research Unit EA3279, Aix-Marseille University, Marseille, France., Beck E; Creativ-Ceutical, London, UK.; GSK, Wavre, Belgium., Cheng X; Creativ-Ceutical Asia Limited, Hong Kong SAR, China., Demarteau N; GSK, Wavre, Belgium., Li X; GSK, Wavre, Belgium., Ma F; Creativ-Ceutical, Beijing, China., Neine M; Creativ-Ceutical, Paris, France., Zhao FH; National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC), Beijing, China.
Publikováno v:
Women's health (London, England) [Womens Health (Lond)] 2020 Jan-Dec; Vol. 16, pp. 1745506520940875.